Myosin Heavy Chain(11C2)Mouse Monoclonal Antibody

Myosin Heavy Chain(11C2)Mouse Monoclonal Antibody

规格:20μL 价格:¥680
规格:50μL 价格:¥1200
规格:100μL 价格:¥2150
应用(Application):IF-P,IF-F,ICC/IF

种属(Reactivity):Human,Mouse,Rat,FruitFly,Nematode
偶联物(Conjugate):Unconjugated
基因名(Gene Name):Myosin Heavy Chain
SKU: AMM04164 Category: 鼠单克隆抗体 Tags: , , , , , , , , ,

说明书 复制

产品概述

产品名称(Product Name)

Acetyl Lysine(10B10)Mouse Monoclonal Antibody

描述(Description)

Mouse monoclonal Antibody

宿主(Host)

Mouse

应用(Application)

WB,IHC,ICC/IF,IP

种属反应性(Reactivity)

Species independent

 

产品性能

偶联物(Conjugation)

Unconjugated

修饰(Modification)

Acetylated

同种型(Isotype)

IgG

克隆(Clonality)

Monoclonal

形式(Form)

Liquid

存放说明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

储存溶液(Buffer)

PBS, pH 7.4, containing 0.5%protective protein, 0.02% New type preservative N as Preservative and 50% Glycerol.

纯化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

别名(Alternative Names)

基因ID(Gene ID)

蛋白ID(SwissProt ID)

 

产品应用

稀释比(Dilution Ratio)

WB 1:1000-1:2000,IHC 1:200-1:500,ICC/IF 1:50-1:200,IP 1:100-1:200

蛋白分子量(Molecular Weight)

 

研究背景

Acetylation of lysine, like phosphorylation of serine, threonine or tyrosine, is an important reversible modification controlling protein activity. The conserved amino-terminal domains of the four core histones (H2A, H2B, H3, and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs). Signaling resulting in acetylation/deacetylation of histones, transcription factors, and other proteins affects a diverse array of cellular processes including chromatin structure and gene activity, cell growth, differentiation, and apoptosis. Recent proteomic surveys suggest that acetylation of lysine residues may be a widespread and important form of posttranslational protein modification that affects thousands of proteins involved in control of cell cycle and metabolism, longevity, actin polymerization, and nuclear transport. The regulation of protein acetylation status is impaired in cancer and polyglutamine diseases , and HDACs have become promising targets for anti-cancer drugs currently in development.

 

研究领域


  • 027-87002838

  • order@enkilife.cn

  • 微信客服
  • 企业微信
  • 在线留言
    关闭